XML 49 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other asset impairments, restructuring and other items (Tables)
9 Months Ended
Sep. 30, 2018
Summary of other impairments, restructuring and other items

Other impairments, restructuring and other items consisted of the following:

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2018      2017      2018      2017  
     (U.S. $ in millions)  

Restructuring expenses

   $ 88      $ 72      $ 442      $ 300  

Integration and acquisition expenses

     4        31        9        87  

Contingent consideration

     29        18        84        179  

Impairments of long-lived assets

     521        408        1,501        564  

Other

     16        21        44        79  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 658      $ 550      $ 2,080      $ 1,209  
  

 

 

    

 

 

    

 

 

    

 

 

 

Components of costs associated with restructuring plan including costs related to exit and disposal activities

The following tables provide the components of costs associated with Teva’s restructuring plan, including other costs associated with Teva’s restructuring plan and recorded under different items:

 

    

Three months ended September 30,

 
    

2018

    

2017

 
    

(U.S. $ in millions)

 

Restructuring

     

Employee termination

  

$

62

 

  

$

54

 

Other

  

 

26

 

  

 

18

 

  

 

 

    

 

 

 

Total

  

$

88

 

  

$

72

 

  

 

 

    

 

 

 
    

Three months ended September 30,

 
    

2018

    

2017

 
    

(U.S. $ in millions)

 

Other

     

Cost of sales

  

$

8

 

  

$

3

 

Selling and marketing expenses

  

 

—  

 

  

 

3

 

Other items

  

 

16

 

  

 

—  

 

    

Nine months ended September 30,

 
    

2018

    

2017

 
    

(U.S. $ in millions)

 

Restructuring

     

Employee termination

  

$

380

 

  

$

228

 

Other

  

 

62

 

  

 

72

 

  

 

 

    

 

 

 

Total

  

$

442

 

  

$

300

 

  

 

 

    

 

 

 
    

Nine months ended September 30,

 
    

2018

    

2017

 
    

(U.S. $ in millions)

 

Other

     

Cost of sales

  

$

23

 

  

$

5

 

Selling and marketing expenses

  

 

—  

 

  

 

3

 

Other items

  

 

54

 

  

 

—  

 


Components of and Changes in Company's Restructuring Accruals

The following table provides the components of and changes in the Company’s restructuring accruals:

 

     Employee
termination costs
     Other      Total  
     (U.S. $ in millions)  

Balance as of January 1, 2018

  

$

(294

  

$

(17

  

$

(311

Provision

  

 

(380

  

 

(62

  

 

(442

Utilization and other*

  

 

418

 

  

 

51

 

  

 

469

 

  

 

 

    

 

 

    

 

 

 

Balance as of September 30, 2018

  

$

(256

  

$

(28

  

$

(284

  

 

 

    

 

 

    

 

 

 

 

*

Includes adjustments for foreign currency translation.